Adhesion Barrier Industry worth $1.11 billion by 2031
The report "Adhesion Barrier Market by Product [Synthetic (Hyaluronic Acid, Polyethylene Glycol), Natural], Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery), End User (Hospitals & Clinics) - Global Forecast to 2031" is projected to reach USD 1.11 billion by 2031 from USD 0.78 billion in 2026, at a CAGR of 7.3% during the forecast period.
Browse 200 market data Tables and 39 Figures spread through 220 Pages and in-depth TOC on "Adhesion Barrier Market by Product [Synthetic (Hyaluronic Acid, Polyethylene Glycol), Natural], Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery), End User (Hospitals & Clinics) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/adhesion-barrier-market-208132543.html
The rapid increase in the number of hospitals and surgical centers is expected to further drive growth in the adhesion barriers market, as these facilities are the primary end users of adhesion prevention products. The expansion of surgical infrastructure across developed and emerging economies, along with the growing patient population, is increasing the demand for advanced surgical products, including adhesion barriers.
Furthermore, the rising number of general, abdominal, gynecological, orthopedic, and other specialty surgeries is contributing to the greater use of adhesion barriers in clinical practice. The growing focus on improving post-surgical outcomes, reducing adhesion-related complications, and minimizing the need for repeat surgeries is encouraging healthcare facilities to incorporate effective adhesion-prevention solutions into routine surgical procedures.
The adhesion barriers market is further segmented by product, formulation, application, end user, and region.
By product, the synthetic adhesion barriers accounted for the largest share of the adhesion barrier market in 2025.
Based on product, the adhesion barriers market is segmented into synthetic and natural adhesion barriers. In 2025, the synthetic adhesion barriers segment accounted for the largest share of the market, primarily due to the broad commercial availability of synthetic products and their greater adoption by surgeons across various surgical procedures compared with natural adhesion barriers. These products are commonly used in open and laparoscopic surgeries, particularly in abdominal, pelvic, gynecological, and other general surgical procedures, where the risk of post-surgical adhesion formation is high.
Gel-based formulations are the fastest-growing segment of the adhesion barrier formulations market.
Based on formulation, the adhesion barriers market is segmented into film, gel, and liquid formulations. In 2025, gel formulations will grow at the highest CAGR in the adhesion barriers market during the forecast period because gel-form adhesion barriers carry a lower risk of anastomotic leaks and associated complications than film-form adhesion barriers. This is one of the major factors driving growth in demand and preference for gel-form adhesion barriers among end users.
North America will continue to dominate the adhesion barriers market in 2031.
The adhesion barriers market has been segmented into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America held the largest share of the adhesion barriers market.
North America leads the adhesion barriers market due to its well-established healthcare infrastructure, high surgical volumes, rapid adoption of advanced surgical products, and strong presence of leading market players. Growth in the region is mainly driven by the rising geriatric population, increasing number of abdominal, gynecological, orthopedic, and other specialty surgeries, and growing awareness regarding post-surgical adhesion-related complications. The rising prevalence of chronic diseases is also expected to increase the number of surgical interventions, thereby supporting the demand for adhesion barriers. In addition, favorable access to advanced healthcare facilities, higher healthcare spending, and the presence of key companies in the US and Canada further contribute to the region’s dominant position in the market.
Key players
The prominent players in the adhesion barrier market include Johnson & Johnson (US), Baxter (US), Medtronic (Ireland), Integra LifeSciences Corporation (US), Anika Therapeutics, Inc. (US), Terumo Corporation (Japan), FzioMed, Inc. (US), MAST Biosurgery (Switzerland), BIOSCOMPASS, Inc. (US), W. L. Gore & Associates, Inc. (US), AlloSource (US), CG Bio Inc. (South Korea), PlantTec Medical GmbH (Germany), Hangzhou Singclean Medical Products Co., Ltd. (China), Gunze Limited (Japan), Samyang Biopharm Corporation (South Korea), BioRegen Biomedical (Changzhou) Co., Ltd. (China), SciVision Biotech Inc. (Taiwan), Kyeron (Netherlands), Betatech Medical (Turkey), Dongsung (South Korea), Womed (France), Proview-MBD Biotech (Taiwan), Semical (Turkey), and Alafair Biosciences (US).
These companies adopted strategies such as partnerships, collaborations, agreements, integrations, acquisitions, product launches, and expansions to strengthen their presence in the adhesion barrier market.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Adhesion Barrier Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
